SiteOne Therapeutics pulls in $15 mln Series B
Bozeman, Montana-based SiteOne Therapeutics, a developer of pain therapeutics and diagnostic tools, has secured $15 million in Series B funding. Amgen led the round with participation from Next Frontier Capital, 2M Companies Inc, Mission Bay Capital, Sears Capital Management, Biobrit LLC and Z Investments.
9 January 2017•1 min read
